Priority Date: 10.07.12 (EP 20120175724)

COMBINATION THERAPY FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION

  • Application ID: EP13732982
  • Status: GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
Employment test 11 - 50 employees
Company dna bohest ag
operating since 1888
825.61
Headquarter in Basel and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 10.07.2012 - Priority Date (EP 20120175724)
  • 16.01.2014 - Publication A1 (WO2014009222)
  • 20.05.2015 - Publication A1 (EP2872505)